Postoperative Delirium in Patients Undergoing Radical Cystectomy
1 other identifier
interventional
50
1 country
1
Brief Summary
In this study, post-operative delirium will be measured in patients undergoing surgery for bladder resection, and associated microRNA biomarkers will be evaluated in patients considered delirious and non-delirious after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedAugust 27, 2021
August 1, 2021
3.1 years
April 5, 2017
August 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative delirium
Evaluate the incidence of and risk factors for POD in patients undergoing radical cystectomy utilizing the Memorial Delirium Assessment Scale.
up to 3 days post-operatively
Secondary Outcomes (1)
microRNA expression
up to 3 days post-operatively
Study Arms (1)
Subjects undergoing radical cystectomy
OTHERSubjects involved in the study will be evaluated with various non-invasive assessments including the Richmond Agitation-Sedation Scale, pain assessments on a Numeric Rating Scale (NRS-11), and CAM-ICU scale. Blood draws will also take place in order to perform microRNA testing in all subjects participating in the trial. Standardized anesthetic care as described by the approved protocol will be followed for each subject included in this trial.
Interventions
These cognitive assessments will be utilized during the study to evaluate cognitive levels comparing prior to surgery and post-operatively in order to determine if the subject is delirious. BIS monitoring will be utilized for all subjects.
Subjects will have blood draws at surgical preadmission visit, Day 1, Day 2, and Day 3 post surgery only; one tube containing approximately one teaspoon (5 mL) of blood will be drawn at each visit.
Standardized anesthetic care will be provided as described by the protocol for each subject consented for this trial.
Eligibility Criteria
You may qualify if:
- Male or female, 18 years of age and older
- ASA II or III
- Capable of and willing to consent
- Participants literate in English language
You may not qualify if:
- ASA IV or V
- Patients with severe visual or auditory impairment
- Inability to read and/or write in English
- Presence of a clinically diagnosed major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia
- Dementia of Alzheimer's type
- Parkinson's disease
- Multiple Sclerosis (MS)
- Vascular dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmad Shabsigh, MD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No masking
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 5, 2017
First Posted
April 27, 2017
Study Start
January 10, 2018
Primary Completion
January 31, 2021
Study Completion
January 31, 2021
Last Updated
August 27, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share